{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New Paltz",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89464",
      "recalling_firm": "Ultra Seal Corporation",
      "address_1": "521 Main St",
      "address_2": "N/A",
      "postal_code": "12561-1609",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0509-2022",
      "product_description": "FEM-PRIN MENSTRUAL RELIEF (acetaminophen 325 mg, pamabrom 25mg) tablets, 2-count packets, Manufactured for: HARTHealth Seattle, WA 98124",
      "product_quantity": "223,090 packets",
      "reason_for_recall": "cGMP deviations",
      "recall_initiation_date": "20220124",
      "center_classification_date": "20220131",
      "termination_date": "20231016",
      "report_date": "20220209",
      "code_info": "Lot #: AK9695, Exp. Date 07/2022"
    }
  ]
}